The MEA’s assertion comes amid an ongoing debate over export of vaccines with some states having flagged a “shortage” of doses and the Centre sustaining that adequate amount of the jabs have been allotted to all of the states and that many of them have been unable to inoculate all eligible beneficiaries.
Asked concerning the standing of made-in-India vaccine export and whether or not domestic calls flagging vaccine shortages might impression the availability abroad, Ministry of External Affairs Spokesperson Arindam Bagchi mentioned, “We have always said the supply of made-in-India vaccines abroad would continue taking into account our domestic requirements.”
“Let me reiterate that there is no ban on export of vaccines. In fact, the website of our ministry is being regularly updated to reflect the supply of vaccines that are happening on a periodic basis,” he mentioned.
On a query on AstraZeneca sending discover to the Serum Institute of India for not fulfilling its worldwide dedication beneath ‘GAVI’ and ‘COVAX’, Bagchi mentioned, “Regarding the issue specific to Serum institute, I would refer you to the company itself, they would be best placed to answer that question.”
On the problem of procurement of uncooked supplies from the US for vaccines manufacturing, the MEA spokesperson recalled that Foreign Secretary Harsh Vardhan Shringla had knowledgeable throughout a media briefing that the problem had been taken up with the US.
India is one of the world’s largest drugmakers, and an growing quantity of international locations have already approached it for procuring anti-coronavirus vaccines.